The second, based on the “sarcomatous” component's expression of cytokeratins (particularly high molecular weight cytokeratin) which is often associated with the expression of mesenchymal antigens like vimentin, focuses on the carcinomatous nature of the proliferation—sarcomatoid carcinoma. The gene discussed is VIM; the disease is sarcomatoid carcinoma.